BioCentury
ARTICLE | Financial News

Zalicus completes debt financing

January 2, 2012 8:00 AM UTC

Zalicus Inc. (NASDAQ:ZLCS), Cambridge, Mass. Business: Autoimmune, Neurology, Inflammation Date completed: 12/19/11 Type: Debt financing Raised: $8.5 million Investor: Oxford Finance Note: Zalicus dre...